Loading...
Evaluation of a new optical immunoassay for diagnosis of neonatal chlamydial conjunctivitis.
Journal Title
Journal of clinical microbiology
Keywords
Readers/Advisors
Journal Title
Term and Year
Publication Date
1997-02
Book Title
Publication Volume
35
Publication Issue
2
Publication Begin
515
Publication End
6
Number of pages
Collections
Files
Research Projects
Organizational Units
Journal Issue
Abstract
The BioStar OIA Chlamydia test (BioStar, Inc., Boulder, Colo.) is a novel immunoassay system that uses changes in reflection of light to directly detect chlamydial antigen in clinical specimens. We compared the optical immunoassay (OIA) with culture for detecting Chlamydia trachomatis in ocular specimens from infants with suspected chlamydial conjunctivitis. We initially performed a retrospective evaluation, testing 152 ocular specimens previously collected for culture with the OIA. The sensitivity and specificity were 94.2 and 97%, respectively. A subsequent prospective study evaluating 37 ocular specimens from infants with suspected C. trachomatis conjunctivitis revealed a sensitivity and specificity of 100 and 92.6%, respectively.
Citation
Roblin PM, Gelling M, Kutlin A, Tsumura N, Hammerschlag MR. Evaluation of a new optical immunoassay for diagnosis of neonatal chlamydial conjunctivitis. J Clin Microbiol. 1997 Feb;35(2):515-6. doi: 10.1128/jcm.35.2.515-516.1997. PMID: 9003631; PMCID: PMC229615.